Prothrombin time (PT) / International normalised ratio (INR), Citrate plasma

Prothrombin time (PT) and international normalized ratio (INR) are tests that evaluate blood clotting time. They help assess the risk of bleeding and thrombosis, and monitor anticoagulant therapy. Test function: Prothrombin time (PT) and international normalized ratio (INR) are tests that measure how quickly blood clots. These markers help evaluate the coagulation system and detect abnormalities, such as blood clotting disorders. They are also used to monitor patients on anticoagulant therapy (e.g., warfarin) to prevent thrombosis and bleeding.
Test significance: These tests are used to diagnose and monitor Liver, disease, blood clotting disorders such as hemophilia, and post-surgical conditions. Prothrombin time and INR are crucial for assessing the risk of thrombosis — the formation of dangerous blood clots in vessels, which can lead to strokes or heart attacks. Patients on anticoagulants need to monitor these levels to avoid both excessive clotting (thrombosis) and the risk of bleeding.
Diseases: Deviations in PT and INR may indicate the risk of bleeding, thrombosis, Liver, disease, and clotting disorders. Monitoring these values is essential for preventing thrombus formation and ensuring the correct anticoagulant dosage.